Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes

OBJECTIVE: To evaluate ITCA 650, a continuous subcutaneous miniature osmotic pump delivery system of exenatide versus twice-daily exenatide injections (Ex-BID) in subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted a randomized, two-stage, 24-week, open-label, phase 2 study in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Robert R., Rosenstock, Julio, Logan, Douglas K., Alessi, Thomas R., Luskey, Kenneth, Baron, Michelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747935/
https://www.ncbi.nlm.nih.gov/pubmed/23645886
http://dx.doi.org/10.2337/dc12-2410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747935/
https://www.ncbi.nlm.nih.gov/pubmed/23645886
http://dx.doi.org/10.2337/dc12-2410

Ejemplares similares